JK Litton
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Immunology
- Molecular Biology
- Co-authors
- JT ChangMustafa KhasrawDaniel J. McGrailNaoto T. UenoMaarten SlagterS.-Y. LinEric JonaschLeonie Voorwerk
- Topics
- Advanced Breast Cancer Therapies (6 papers)BRCA gene mutations in cancer (6 papers)Breast Cancer Treatment Studies (5 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- United StatesSouth KoreaFrance
In The Last Decade
JK Litton
16 papers receiving 732 citations
Hit Papers
Peers
Comparison fields: 5 of 53
- Oncology 536
- Pulmonary and Respiratory Medicine 295
- Cancer Research 238
- Immunology 198
- Molecular Biology 175
Countries citing papers authored by JK Litton
This map shows the geographic impact of JK Litton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JK Litton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JK Litton more than expected).
Fields of papers citing papers by JK Litton
This network shows the impact of papers produced by JK Litton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JK Litton. The network helps show where JK Litton may publish in the future.
Co-authorship network of co-authors of JK Litton
This figure shows the co-authorship network connecting the top 25 collaborators of JK Litton. A scholar is included among the top collaborators of JK Litton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JK Litton. JK Litton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer typesbreakdown → | 672 |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 0 | |
| 9 | 2 | |
| 10 | 0 | |
| 11 | 2 | |
| 12 | 2 | |
| 13 | 7 | |
| 14 | 0 | |
| 15 | 1 | |
| 16 | 17 | |
| 17 | 2 | |
| 18 | 7 | |
| 19 | 14 |
About JK Litton
JK Litton is a scholar working on Cancer Research, Oncology and Genetics, having authored 19 papers that have together received 733 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (6 papers), BRCA gene mutations in cancer (6 papers) and Breast Cancer Treatment Studies (5 papers). The work is most often cited by research in Oncology (536 citations), Cancer Research (238 citations) and Immunology (198 citations). JK Litton has collaborated with scholars based in United States, South Korea and France. Frequent co-authors include JT Chang, Mustafa Khasraw, Daniel J. McGrail, Naoto T. Ueno, Maarten Slagter, S.-Y. Lin, Eric Jonasch, Leonie Voorwerk, Bora Lim and Renata Ferrarotto. Their work appears in journals such as Cancer Research, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.